Editas Medicine (EDIT) reports disappointing Q1 results with a wider net loss, significant decline in revenue, and higher operating expenses
https://seekingalpha.com/news/4102550-editas-medicine-down-9-following-rough-q1-results
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.